NCT03527680View on ClinicalTrials.gov

Effect of Lactobacillus Rhamnosus on Serum Uremic Toxins in Hemodialysis

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

December 30, 2016

Conditions
Hemodialysis Complication
Interventions
DIETARY_SUPPLEMENT

Lactobacillus rhamnosus

daily one capsule containing 1.6\*107 CFU of Lactobacillus Rhamnosus prepared by Tabriz Nutrition Research Center from yogurt and cheese of different farms located in the suburbs Heris, after meal for 28 days

DRUG

Placebo - Cap

daily one capsule of placebo

All Listed Sponsors
lead

nooshin dalili

OTHER

NCT03527680 - Effect of Lactobacillus Rhamnosus on Serum Uremic Toxins in Hemodialysis | Biotech Hunter | Biotech Hunter